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A new siderophore containing a 4,5-dihydroimidazole moiety was isolated from 
Pseudoalteromonas piscicida S2040 together with myxochelins A and B, alteramide A and its 
cycloaddition product, and bromo- and dibromoalterochromides. The structure of pseudochelin 
A was established by spectroscopic techniques including 2D NMR and MS/MS fragmentation 
data. In bioassays selected fractions of the crude extract of S2040 inhibited the opportunistic 
pathogen Pseudomonas aeruginosa. Pseudochelin A displayed siderophore activity in the 
chrome azurol S assay at concentrations higher than 50 μM, and showed weak activity against 
the fungus Aspergillus fumigatus, but did not display antibacterial, anti-inflammatory or 
anticonvulsant activity. 
2016 Elsevier Ltd. All rights reserved. 
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1. Introduction 
The element iron is an essential nutrient for growth of most 
microorganisms as it is required for important biological 
processes such as nitrogen fixation, amino acid synthesis, 
respiration, photosynthesis, DNA biosynthesis, and the citric acid 
cycle.[1] However, it occurs at very low levels in most natural 
environments, and the concentration for instance is  below 0.5 
nM in oceanic oxygenated waters at pH 7.[2] In order to obtain 
sufficient iron for their physiological needs most microorganisms 
have evolved biosynthetic strategies to cope with this deficiency. 
One of these is the production of siderophores,[3] which are 
small molecular weight chelating molecules that can help 
transport the insoluble iron (Fe3+) into the cell via cell membrane 
specific receptor proteins.[1] Once inside the cell the complexed 
iron3+ is released via reduction, ligand exchange or hydrolytic 
mechanisms[4] to Fe2+ soluble species.  
There are three known classes of iron chelating moieties: 
phenols and catechols as in enterobactins,[5] hydroxamates (N-
OH amides) as in the desferrioxamines,[6,7] and -
hydroxycarboxylic acids as in achromobactin.[8,9] A closer look 
at these structures shows the presence of a high number of 
oxygen groups that can form ligands with positively charged 
cations. Oxygen ligands are well known for their high affinity for 
iron (III) species which has possibly resulted in the evolutionary 
selection of these groups by the microbial biosynthetic 
machinery.[10] In most of the cases, each ligand is an OO′ donor 
and each of the siderophores is able to form tris OO′ coordination 
to form the stable octahedral complex of the ferric ion.[1,10]  
There are not many marine derived siderophores known 
compared to terrestrial ones. So far, the majority of the structures 
belong to a family of amphiphilic compounds containing an 
iron(III)-binding headgroup that is appended by a series of fatty 
acids.[1,11] The headgroup either contains a small peptide 
between 4-7 amino acids as in the amphibactins[12] or the -
hydroxycarboxylic acid moiety in the form of an -
hydroxyaspartic acid or citric acid as in the case of the 
synechobactins.[13] Many microbes produce only one type of 
siderophore but, many, particularly infectious pathogenic 
ones[14,15] are known to produce multiple siderophores, 
including mixed-type ligands[16] as exemplified by the 
mycobactins that contain catechol, hydroxyamine and oxazole 
units.[17] Others contain thiazole as exemplified by 
pyochelin.[18] These features are believed to offer advantages to 
the microorganisms in their ability to evade the host response to 
continue sequestering iron from their environment in order to 
survive.[17,19] Furthermore, siderophores have been known to 
inhibit the growth of various phytopathogenic fungi such as 
Phytophthora parasitica,[20] Phythium ultimum,[21] and 
Fusarium oxysporum f.sp.dianthi.[22] 
 
 
 
 
 
 
 
 
 
 
We report herein the isolation and structure elucidation of a 
new mixed-ligand siderophore, pseudochelin A (1) containing 
catechols and a 4,5-dihydro-imidazole moiety. Interestingly, we 
also isolated the known compounds myxochelins A and B that 
have been known to be produced only by myxobacteria.[23] 
Additionally, the known compound alteramide A and its 
[4+4]cyclo-addition product A were also isolated.[24] Finally, 
dereplication by LCMS and proton NMR also suggested the 
presence in the extracts of mono and dibromo-
alterochromides.[25] The presence of three different classes of 
compounds demonstrates the wide biosynthetic capability of this 
strain. 
2. Results and Discussion 
The crude extract of the culture of Pseudoalteromonas 
piscicida S2040 was fractionated by reversed phase solid phase 
extraction (SPE) before further purification by reversed phase 
HPLC to yield pseudochelin A (1) and six known compounds (2-
7). The known compounds were identified by 1H NMR, 
HRESIMS, and MS/MS data. Pseudochelin A (1) showed a high 
resolution ESIMS of m/z 386.172 [M+H]+ (Δ 0.5 ppm) from 
calculated for C20H24N3O5 and requiring 11 degrees of 
unsaturation. Interpretation of 1H, HMBC and edited HSQC 
NMR spectra (Figure S1-S4) of compound 1 indicated the 
presence of five methylenes, seven methines and eight quaternary 
carbons leading to the sub-formula C20H17. The presence of six 
methines (δc 119.9, 119.8, 118.7, 118.2, 118.1 and 117.2) and six 
quaternary carbons (δc 148.7, 147.5, 146.1, 145.9, 115.5 and 
107.8) suggested the presence of two aromatic rings, which 
together with the presence of two additional quaternary carbons 
at δc 170.1 and δc 163.1 accounted for a total of 10 double bond 
equivalents. This suggested the presence of a third ring in the 
structure of 1 to complete the 11 degrees of unsaturation. Use of 
one- and two-dimensional NMR data enabled the construction of 
4 substructures (Figure 1). 
 
 
 
 
 
 
 
Figure 1. Substructure A-D of compound 1 with COSY and key 
HMBC correlations. 
Inspection of the 1H and 13C NMR chemical shifts, 1H-1H 
coupling constants and COSY data suggested the presence of two 
similar, but isolated aromatic spin systems (substructures A and 
D, Figure 1) consistent with the presence of two catechol sub-
units. The adjacent units attached to these two systems however, 
were different. A HMBC correlation from H 7.18 to C 170.1 
indicated the presence of an amide unit in substructure A. A more 
shielded quaternary carbon at C 163.0 that correlated to the 
signal at H 7.14 by HMBC suggested a different functional 
group was adjacent to substructure D. Long range HMBC 
correlations linked the proton signals at H 4.12/3.71, H 4.36 and 
H 7.14 to the quaternary carbon signal C 163.0 suggesting the 
presence of a 4,5-dihydro-imidazole unit (substructure C). The 
butyl chain was readily assigned by COSY and HMBC 
correlations (substructure B). The four substructures were 
assembled by long range HMBC correlations to give 
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pseudochelin A (1) representing a new 4,5-dihydroimidazole-
catechol-type siderophore.  
 
 
 
Table 1 
NMR data for pseudochelin A (1) in CD3OD 
 
Pos. Ca, type Hb (J in Hz) COSY (
1H-1H) HMBC  
1 49.1, CH2 A: 4.12, dd (11.6, 11.2) 2 2, 3, 7' 
    A:3.71, dd (11.7, 11.5) 2 2, 3, 7' 
2 56.7, CH 4.36, m 1A, 1B, 3A, 3B 1, 7' 
3 34.2, CH2 A: 1.86, m 2, 4A, 4B 2 
    B: 1.77, m 2, 4A, 4B 2 
4 21.5, CH2 A:1.52, m 3A, 3B, 5 5, 6 
    B: 1.48, m 3A, 3B, 5 5, 6 
5 28.8, CH2 1.70, m 4A, 4B, 6 3, 4, 6 
6 38.5, CH2 3.45, t (6.9) 5 4, 5, 7" 
1' 107.8, C       
2' 147.5, C       
3' 146.1, C       
4' 119.9, CH 7.08, dd (8.1, 0.6) 5' 2', 3', 6' 
5' 119.8, CH 6.84, dd (8.1, 8.1) 4', 6' 1', 3' 
6' 118.7, CH 7.14, dd (8.1, 0.6) 5' 2', 4', 5', 
7', 
7' 163.0, C       
1" 115.4, C       
2" 148.7, C       
3" 145.9, C       
4" 118.1, CH 6.91, dd (8.0, 1.2) 5" 2",3", 6" 
5" 118.2, CH 6.70, dd (8.0, 8.0) 4", H6" 1", 3" 
6" 117.2, CH 7.18 dd (8.0, 1.2) 5" 2", 4", 
5",7" 
7" 170.1, C       
 
Coupling constants are in brackets and given in Hz.  
a150 MHz 
b400 MHz 
 
 
Further supporting evidence of the structure came from MS/MS 
fragmentation data (Figure S6). 
 
The absolute stereochemistry of compound 1 was determined to 
be S by comparing the experimental circular dichroism spectrum 
with the theoretical spectrum calculated using self-interaction 
corrected time-dependent density functional theory within the 
real-space time-propagation framework (S1). The best fit was 
obtained between the experimental spectrum and the CD 
spectrum simulated for the 2S configuration (Figure 2). 
 
 
 
Figure 2. Experimental (black) and calculated (red) spectra of 
pseudochelin A (1). 
 
Pseudochelin A can potentially exist in two tautomeric forms in 
solution as shown in Figure 3. Correlation of 13C experimental 
and calculated chemical shift values did not show any significant 
difference between the two structures based on the regression 
coefficient values[26] (Figure 4).  
 
 
 
 
 
 
 
 
 
 
Figure 3. Tautomeric forms of pseudochelin A (1). 
 
 
 
Figure 4.  Experimental vs predicted 13C data for the two 
tautomers of 1. 
 
Pseudochelin A (1) complexes iron (III) as colour changes were 
observed after the addition of 1 to Fe3+ solutions (Figure S7), and 
the appearance of a broad absorption maximum at 572 nm in the 
UV spectrum in MeOH (Figures S8, S9). It also showed a 
HRESIMS m/z of 439.0827 (M+H)+ (Δ 0.4 ppm) from calculated 
for C20H21N3O5Fe (Figure S10) suggesting three donor groups 
were involved in the formation of the ferric-pseudochelin A 
complex. The identity of these donor groups have not been 
determined yet even though any combination of three of the four 
catechol units is possible based on known binding mechanism of 
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catechol-type siderophores.[3,27] Analogous compounds such 
as agrobactin and parabactin are known to utilize the nitrogen in 
the central oxazoline ring to form , cis coordination 
compounds.[28] The metal biding properties of pseudochelin A 
is currently being investigated and will be discussed elsewhere. 
Pseudochelin A is likely to originate from non-ribosomal 
peptide synthetase (NRPS) assembly line, a similar biosynthetic 
pathway to the one reported for myxochelins A and B,[23] where 
the aldehyde intermediate 2 is generated through the reduction of 
the peptidyl carrier protein (PCP)-bound thioester in the NRPS 
assembly line. The transamination on 2 yields myxochelin B (3) 
which can undergo cyclization to produce 1 (Scheme 1).  
 
 
  
 
 
 
 
 
Scheme 1. Plausible biogenetic pathway of pseudochelin A 
(1) 
The four crude SPE fractions of Pseudoalteromonas piscicida 
S2040 were initially screened for antibacterial and antifungal 
activities. All fractions showed minor inhibitions (14-16%) of 
Staphylococcus aureus MRSA-MB5393. The fraction (SPE 100) 
showed a 62% growth inhibition of Pseudomonas aeruginosa 
while the fraction (SPE 25) showed a minor inhibition (12%) of 
Candida albicans MY1055. Pseudochelin A (1) was evaluated in 
these assays, but did not show any significant activity except for 
a weak antifungal activity against Aspergillus fumigatus 
ATCC46645 (MIC85 = 32 μg/mL). Further evaluation of 1 in the 
anti-inflammatory, and the zebra-fish-assay for anticonvulsant or 
neurobehavioral activity showed no positive results. 
In summary, we have discovered a new structure containing the 
4,5-dihydroimidazole moiety with siderophore activity. Even 
though the role of the 4,5-dihydromimidazole in pseudochelin A 
in iron-chelation has not been determined, the structure shows 
similarity to other known ‘mixed-ligand’ class of siderophores 
exemplified by mycobactins[11], agrobactin[28], parabactin[28] 
vibriobactin[29,30], and pyochelin.[6,18] Mixed-ligands 
siderophores have attracted some attention about possible roles in 
virulence ‘stealth’ enabling their producers to avoid detections by 
the mammalian host defense mechanisms during cellular 
infections allowing them to continue sequestering iron from their 
host.[1,31–33] The results of biological assays have suggested 
that other compounds in the crude extract may be responsible for 
the observed activity against Pseudomonas aeruginosa as 
pseudochelin A did not show any antibacterial activity. The other 
compounds: myxochelin A, alteramides A, bromo- and dibromo-
alterochromides are known for their cytotoxicity 
activity.[24,25,34] 
 
3. Experimental section 
3.1 General Experimental Procedures  
NMR data, both 1D and 2D were recorded on a Bruker 
AVANCE III HD spectrometer at 400 and 100 MHz for 1H and 
13C respectively in CD3OD (Cambridge Isotope Laboratories) 
using a 5 mm SmartProbe. High resolution mass spectrometry 
data were recorded using a Waters LCT Premier coupled to a 
Waters Acquity UPLC system, and a ThermoScientific LTQXL-
Discovery Orbitrap coupled to an Accela HPLC system. The 
Waters LCT Premier MS system used the following conditions: 
capillary voltage 2600 V, cone voltage 50 V, desolvation 
temperature 350 °C, desolvation gas 650 L/h, cone gas 5 L/h, 
mass range 150-1500 amu. The instrument was tuned to a 
resolution of 10,000 (FWHM) and leucine-enkephaline was used 
as lock mass for internal calibration.  For the LTQXL-Discovery 
Orbitrap, the following conditions were used: capillary voltage 
45 V, capillary temperature 320 °C, auxiliary gas flow rate 10-20 
arbitrary units, sheath gas flow rate 40-50 arbitrary units, spray 
voltage 4.5 kV, mass range 100-2000 amu (maximum resolution 
30,000). The optical rotation measurement was recorded using a 
Bellingham & Stanley, Model ADP410 Polarimeter at 589 nm. 
Semi-preparative HPLC purifications were performed on an 
Agilent 1100 HPLC system consisting of a solvent compartment, 
degasser, binary pump, autosampler, diode array detector (DAD) 
and a preparative fraction collector. The UV/Vis absorption of 
the pseudochelin A-Fe3+ complex was measured by HPLC using 
a Phenomenex HPLC C4 column (50 x 4.6 mm, 5 m, 300 Å) 
and using a linear gradient from 0 to 100% (MeOH in water) in 
15 minutes. All solvents used in this study were either of HPLC 
or LCMS grade. 
 
3.2 Bacterial strain 
Pseudoalteromonas piscicida S2040 was isolated during the 
global research cruise Galathea 3 due to its bioactivity against the 
human pathogen Staphylococcus aureus NCTC 8325 and the fish 
pathogen Vibrio anguillarum 90-11-287 (serotype O1).[35] 
S2040 was obtained from a copepod sampled from surface water 
off the Northwestern coast of Australia (-16.06 N, 119.354 E). 
 
3.3 Culture  
S2040 was routinely grown on Marine Agar 2216 (MA) at 
25°C. For the initial screening, S2040 was pre-cultured overnight 
in 5 mL SCM (2% sea salts (Sigma-Aldrich[36], S4), 0.3% 
casamino acids, 0.4% mannose) at 200 rpm and 25°C. A 500 mL 
baffled Erlenmeyer flask containing 150 mL SCM was 
inoculated with 750 µl pre-culture and incubated at 200 rpm and 
25°C. After 48 h, 1.8 g sterilized Diaion® HP-20 resin (Sigma-
Aldrich) was added to the culture and incubation was continued 
for 24 h. 
Resin and cells were separated by centrifugation for 20 min at 
3059 x g. The resin was washed with MilliQ water and extracted 
with MeOH. The cell pellet was extracted with EtOAc/MeOH 
(8:2, v/v), and combined with the resin extract. The crude extract 
was dried under nitrogen. Upscaling was performed accordingly 
in 2 L SCM in 10 L Nalgene flasks and upon addition of 24 g 
Diaion® HP-20 resin (Sigma-Aldrich)[36] 
 
3.4 Fractionation and isolation 
The crude sample was fractionated on a C18 solid phase 
extraction (SPE) column using 25% MeOH in water (SPE 25), 
followed by 50% MeOH (SPE 50), then by 100% MeOH (SPE 
100). Finally, the column was flushed with 100% methanol 
containing 0.05% trifluoroacetic acid (SPE 100+TFA). The 
compounds of interest were detected in the SPE 50 fraction by 
LC-MS and 1H NMR analysis. Purification of this fraction was 
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carried out by reversed phase C18 HPLC using a mixture of 
MeOH, water and TFA (0.05%) as an eluent with a linear 
gradient from 0-100% MeOH over 25 min and a solvent flow of 
2 mL/min to yield 1 (6.3 mg), 2 (2.1 mg) and 3 (2.5 mg). 
Purification of the SPE 100 fraction was carried out by reversed 
phase C18 HPLC using a mixture of MeOH and water as eluent 
with a three step gradient from 60-80% MeOH over 10 min, 
followed by 80-100% MeOH over 15 min, and finally by 100% 
MeOH over 20 min. In addition, the solvent flow rate was 
reduced from 2.0 to 1.4 mL/min in the first step and then 
increased in the third step from 1.4 to 2.0 mL/min to yield 4 (2.3 
mg), 5 (2.1 mg) and a mixture of 6 and 7 (3.5 mg). 
Pseudochelin A (1). Brownish oil, 6.3 mg; [α]25D -51.3 (c 1.01 
MeOH); IR (cm-1) 3240, 2945, 2867, 1675, 1640, 1625, 1590, 
1565, 1460, 1355, 1248, 1200, 1140, 840, 800, 725 (Figure S11); 
1H NMR and 13C NMR (MeOD-δ4) see Table 2; HRESIMS m/z 
386.172 [M+H]+ (Δ 0.5 ppm) from calculated for C20H24N3O5. 
 
3.4 Biological activities 
All the SPE fractions of S2040 were tested for their ability to 
inhibit the growth of Gram-negative and Gram-positive bacteria 
(Escherichia coli MB2884, Acinetobacter baumannii MB5973, 
Pseudomonas aeruginosa PAO-1, and methicillin-resistant 
Staphylococcus aureus MRSA, MB5393), fungi (Aspergillus 
fumigatus ATCC46645) and yeast (Candida albicans MY1055) 
following previously described methodologies.[37,38] Briefly, 
each compound was serially diluted in DMSO with a dilution 
factor of 2 to provide 10 concentrations starting at 64 μg/mL for 
all the assays. The MIC was defined as the lowest concentration 
of compound that inhibited ≥90% of the growth of a 
microorganism after overnight incubation. The Genedata 
Screener software[39] was used to process and analyze the data 
and also to calculate the RZ’ factor, which predicts the robustness 
of an assay.[40] In all experiments performed in this work the 
RZ’ factor obtained was between 0.87 and 0.98. 
Furthermore, the SPE fractions were tested for their anti-
inflammatory activity by inhibition of TNFα production in LPS-
stimulated monocytes (THP-1 cells) using sELISA.[41]  
The pure compound pseudochelin A (1) was re-evaluated in 
all the above assays. The siderophore activity was performed 
using the chrome azurol S assay.[42] The zebrafish larvae assay 
for anticonvulsant activity was carried out using previously 
described methods (S2). 
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